Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based Pall Corporation has purchased GeneSystems, a privately held French biotechnology company that has developed a molecular diagnostics platform.
Subscribe to our email newsletter
The acquisition of GeneSystems, with its patented approach to rapid microbiological detection equipment and disposables, expands Pall’s total fluid management capabilities in the $1 billion biopharmaceuticals process monitoring market.
The acquisition also presents Pall with new opportunities in its environmental, food and beverage and water markets.
Eric Krasnoff, Pall Corporation’s chairman and CEO, said: “Customers seek better tools for rapid testing and process monitoring. GeneSystems expands our ability to provide total fluid management to meet customer’s raw materials, production, testing and environmental requirements. GeneSystems’s unique technologies complement Pall’s markets and global reach.”